SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 22.50% in the revenue at Rs. 14952.50 millions was reported in the June 2022 quarter as compared to Rs. 12206.00 millions during year-ago period.Profit after tax improved marginally to Rs. 2316.10  millions for the quarter ended June 2022 from Rs. 2220.80 millions of corresponding previous quarter.Operating profit surged to 4211.10 millions from the corresponding previous quarter of 3706.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 14952.50 12206.00 22.50 14952.50 12206.00 22.50 47070.40 47687.20 -1.29
Other Income 29.30 75.70 -61.29 29.30 75.70 -61.29 215.50 273.20 -21.12
PBIDT 4211.10 3706.30 13.62 4211.10 3706.30 13.62 13067.50 15371.90 -14.99
Interest 275.00 250.40 9.82 275.00 250.40 9.82 958.60 659.20 45.42
PBDT 3936.10 3455.90 13.90 3936.10 3455.90 13.90 12108.90 14712.70 -17.70
Depreciation 660.00 554.90 18.94 660.00 554.90 18.94 2354.80 1966.40 19.75
PBT 3276.10 2901.00 12.93 3276.10 2901.00 12.93 9754.10 12746.30 -23.48
TAX 960.00 680.20 41.13 960.00 680.20 41.13 2253.20 3185.20 -29.26
Deferred Tax -69.80 174.30 -140.05 -69.80 174.30 -140.05 -61.00 -164.60 -62.94
PAT 2316.10 2220.80 4.29 2316.10 2220.80 4.29 7500.90 9561.10 -21.55
Equity 1074.70 1073.20 0.14 1074.70 1073.20 0.14 1074.70 1073.20 0.14
PBIDTM(%) 28.16 30.36 -7.25 28.16 30.36 -7.25 27.76 32.23 -13.88

Laurus Labs Share Price

1180.35 16.35 (1.40%)
06-May-2026 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.80
Dr. Reddys Lab 1316.50
Cipla 1365.75
Zydus Lifesciences 942.00
Lupin 2444.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×